A randomized, double-blinded, controlled, multicenter clinical trial of linezolid versus vancomycin in the treatment of gram positive bacterial infection

Chinese Journal of Infection and Chemotherapy

Volumn 9, Issue 1, 2009, Pages 10-17

  Lin, Dong Fang ^a   Wu, Ju Fang ^a   Zhang, Ying Yuan ^a   Zheng, Jing Chuan ^a   Miao, Jing Zhi ^a   Zheng, Li Ye ^a   Sheng, Rui Yuan ^a   Zhou, Xin ^a   Shen, Hua Hao ^a   Wu, Wei Hong ^a   Zhou, Le ^a   Wang, Fu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Complicated skin and soft tissue infection; Linezolid; Pneumonia; Vancomycin

Indexed keywords

AMIKACIN; CEFALOTIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; LINEZOLID; OXACILLIN; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; LEUKOPENIA; LIVER DYSFUNCTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; NONHUMAN; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; SKIN INFECTION; SOFT TISSUE INFECTION; THROMBOCYTOPENIA;

EID: 59349085321     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Klevens RM, Edwards JR, Tenover FC, et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003[J]. Clin Infect Dis,2006,42(3):389-391.
2. Styers D, Sheehan DJ, Hogan P, et al. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States[J]. Ann Clin Microbiol Antimicrob, 2006,5:2.
3. Chinese source.
4. Chinese source.
5. Chinese source.
6. Shinabarger DL, Marotti KR, Murray RW, et al. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid of translation reactions[J]. Antimicrob Agents Chemother, 1997,41(10):2132-2136.
7. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia[J]. Am J Respir Crit Care Med, 2005,171(4): 388-416.
8. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections[J]. Clin Infect Dis, 2005,41(10):1373-1406.
9. Gemmell CG, Edwards DI, Fraise AP, et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK[J]. J Antimicrob Chemother, 2006,57(4):589-608.
10. French G. Safety and tolerability of linezolid[J]. J Antimitrob Chemother, 2003, 51(Suppl 2):ii45-53.
11. Green SL, Maddox JC, Huttenbach ED. Linezolid and reversible myelosuppression[J]. JAMA, 2001,285(10):1291.